In today’s digital landscape, organizations face the dual challenge of driving technological innovation while safeguarding ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

With the right narrative, you can position your company as a visionary force worth investing in, turning your North Star into ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a ...

The B2B sales landscape is undergoing a rapid transformation. Economic uncertainty, shifting buyer expectations, and technologies like generative AI are compelling sales leaders to rethink how they ...

In fintech, where every line of code has the potential to impact the financial ecosystem, one professional stands out for her ...

Researchers at the Kennedy Institute have developed a new computational framework that allows simultaneous analysis of gene expression and mechanical forces within cells and tissues, uncovering ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.